Atlas Trials

Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients

Clinical trial NCT04610502 · COMPLETED

Trial details

NCT number
NCT04610502
Sponsor
Caja Costarricense de Seguro Social
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2020-09-06
Primary completion
2020-10-06
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.